Tailoring Head and Neck Cancer Therapy: Insights from the 3D-OTC Model in vitro - Top-Institutions - MDSpire

Tailoring Head and Neck Cancer Therapy: Insights from the 3D-OTC Model in vitro

  • By

  • Fabian Stögbauer

  • Tobias Weiser

  • Ali Bashiri Dezfouli

  • Johannes Wirth

  • Luca Engelmann

  • Jan Budczies

  • Iordanis Ourailidis

  • Melanie Boxberg

  • Katharina Pigorsch

  • Benedikt Schmidl

  • Nicole Strittmatter

  • Katja Steiger

  • Carolin Mogler

  • Barbara Wollenberg

  • April 25, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Head and Neck Oncology
    • Translational Cancer Research
    • Immuno-oncology

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Head and Neck Surgical Oncology
    • Molecular Oncology
    • Cancer Immunology

  • #3

    Technical University of Munich (TUM) Klinikum
    Technical University of Munich (TUM) Klinikum

    Munich, Bavaria

    Key Differentiators

    • Otolaryngology
    • Head and Neck Cancer Research
    • 3D Tissue Culture Models

  • #4

    University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center
    University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center

    San Francisco, CA

    Key Differentiators

    • Head and Neck Oncology
    • Cancer Biology
    • Immunotherapy

  • #5

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Cancer Research
    • Head and Neck Oncology
    • Molecular Pathology

Original Source(s)

Tailoring Head and Neck Cancer Therapy: Insights from the 3D-OTC Model in vitro

  • by Fabian Stögbauer, Tobias Weiser, Ali Bashiri Dezfouli, Johannes Wirth, Luca Engelmann, Jan Budczies, Iordanis Ourailidis, Melanie Boxberg, Katharina Pigorsch, Benedikt Schmidl, Nicole Strittmatter, Katja Steiger, Carolin Mogler, Barbara Wollenberg

  • April 25, 2026

Related Content

Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry

Data requirements of an informative, directive, and preventive mobile health application for gastric cancer

Case Report: First description of an intracranial “NET” in ROHHAD syndrome; time to rename to the ROHHAD-NeCT syndrome?